LENZ Therapeutics

IPO

LENZ Therapeutics is a biotech company in Burlingame, United States, founded in 2013. It has raised $160.5M across 3 rounds, most recently a $30.0M Private Equity in July 2024.

Striving to restore vision

Employees
51–200
Founded
2013
Business Model
B2C
Total Funding
$160.5M
Last Round
$30.0M Private EquityJul 2024
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia. LENZ is commercializing VIZZ in the United States and continues to establish licensing partnerships internationally to provide access to VIZZ globally. The lead program aims to restore near vision with a once-daily drop for a condition that impacts 128 million people in the United States.

Summary

It lists 51–200 employees. It has raised $160.5M in total across 3 rounds, most recently a $30.0M Private Equity round in Jul 2024. Investors include Ridgeback Capital, Sectoral Asset Management and Versant Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Private EquityPrivate EquityJul 2024
$30.0M

Sign up to see all 4 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

LENZ Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/lenz-therapeutics"><img src="https://indexed.vc/api/badge/company/lenz-therapeutics" alt="LENZ Therapeutics on Indexed.vc" width="260" height="76" /></a>